Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
International Archives of Allergy and Applied Immunology
|
January 1, 1981
Nonimmune complexes of pregnancy-specific beta 1-glycoprotein explain its heterogeneity
L Tamsen, M Inganäs, S G Johansson, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
January 1, 1984
Pregnancy-specific beta 1-glycoprotein, SP1, in maternal serum during uncomplicated single pregnancies
L Tamsen, M Inganäs, S G Johansson, et al.
Gynecologic Oncology
|
October 1, 1990
Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of disease
B Tholander, A Taube, A Lindgren, et al.
Gynecologic Oncology
|
October 1, 1990
Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis
B Tholander, A Taube, A Lindgren, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
International Archives of Allergy and Applied Immunology
|
January 1, 1981
Nonimmune complexes of pregnancy-specific beta 1-glycoprotein explain its heterogeneity
L Tamsen, M Inganäs, S G Johansson, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
January 1, 1984
Pregnancy-specific beta 1-glycoprotein, SP1, in maternal serum during uncomplicated single pregnancies
L Tamsen, M Inganäs, S G Johansson, et al.
Gynecologic Oncology
|
October 1, 1990
Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of disease
B Tholander, A Taube, A Lindgren, et al.
Gynecologic Oncology
|
October 1, 1990
Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis
B Tholander, A Taube, A Lindgren, et al.
Page
of 2